Ironvine Capital Partners’s Pfizer PFE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$402K	Hold	16,600	–	–	0.04%	46
2025 Q1	$421K	Hold	16,600	–	–	0.05%	46
2024 Q4	$440K	Hold	16,600	–	–	0.05%	44
2024 Q3	$480K	Sell	16,600 -353	-2%	-$10.2K	0.05%	43
2024 Q2	$474K	Hold	16,953	–	–	0.05%	42
2024 Q1	$470K	Buy	16,953 +353	+2%	+$9.8K	0.05%	42
2023 Q4	$478K	Hold	16,600	–	–	0.06%	42
2023 Q3	$551K	Hold	16,600	–	–	0.07%	41
2023 Q2	$609K	Hold	16,600	–	–	0.07%	40
2023 Q1	$677K	Hold	16,600	–	–	0.09%	41
2022 Q4	$851K	Hold	16,600	–	–	0.11%	43
2022 Q3	$726K	Hold	16,600	–	–	0.1%	45
2022 Q2	$870K	Hold	16,600	–	–	0.11%	45
2022 Q1	$859K	Hold	16,600	–	–	0.09%	45
2021 Q4	$980K	Hold	16,600	–	–	0.1%	44
2021 Q3	$714K	Hold	16,600	–	–	0.08%	46
2021 Q2	$650K	Sell	16,600 -58,452	-78%	-$2.29M	0.07%	47
2021 Q1	$2.72M	Hold	75,052	–	–	0.32%	40
2020 Q4	$2.76M	Sell	75,052 -4,053	-5%	-$149K	0.35%	37
2020 Q3	$2.75M	Hold	79,105	–	–	0.35%	35
2020 Q2	$2.45M	Hold	79,105	–	–	0.32%	37
2020 Q1	$2.45M	Buy	79,105 +19,415	+33%	+$601K	0.38%	34
2019 Q4	$2.22M	Hold	59,690	–	–	0.31%	40
2019 Q3	$2.07M	Hold	59,690	–	–	0.3%	41
2019 Q2	$2.43M	Hold	59,690	–	–	0.4%	36
2019 Q1	$2.41M	Hold	59,690	–	–	0.45%	34
2018 Q4	$2.24M	Hold	59,690	–	–	0.46%	32
2018 Q3	$2.5M	Hold	59,690	–	–	0.51%	32
2018 Q2	$2.06M	Buy	59,690 +22,144	+59%	+$762K	0.46%	35
2018 Q1	$1.26M	Buy	37,546 +17,971	+92%	+$605K	0.3%	50
2017 Q4	$673K	Buy	+19,575	New	+$673K	0.21%	67